Strategic Blueprint, LLC
Source: SEC Form 13F · as of Mar 2026Strategic Blueprint, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $23.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$23.7M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 12,266 | $11.3M |
| JNJJOHNSON & JOHNSON | 11,985 | $2.9M |
| ABBVAbbVie Inc. | 9,477 | $2.1M |
| MRKMerck & Co., Inc. | 12,915 | $1.6M |
| PMPhilip Morris International Inc | 7,741 | $1.3M |
| PFEPFIZER INC | 33,185 | $932K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,232 | $604K |
| AMGNAMGEN INC | 1,275 | $449K |
| ABTABBOTT LABORATORIES | 4,091 | $420K |
| BMYBRISTOL MYERS SQUIBB CO | 6,151 | $373K |
| GILDGILEAD SCIENCES, INC. | 2,470 | $344K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 721 | $322K |
| GMOptec International, Inc. | 3,609 | $269K |
| SIGASIGA TECHNOLOGIES INC | 50,000 | $268K |
| IDXXIDEXX LABORATORIES INC /DE | 455 | $256K |
| CORCencora Inc. | 766 | $241K |
| ATAIAtai Beckley N.V. | 23,500 | $83K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.